Should I buy Procter & Gamble (PG) stock or is it too late?
⭐ The most reliable of them, either direction: Evercore ISI Group — 69% of its targets hit on this sector (129 calls tested). It aims for $166 (+8.5 %), call made on October 7, 2026, maturing on October 7, 2027 (7 d ago).
Firm-by-firm track record on Procter & Gamble
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| B of A Securities | 73 % | +11.9 % | 11 | $166 +8% |
| Citigroup | 68 % | +9.5 % | 19 | $170 +11% |
| Jefferies | 86 % | +7.5 % | 7 | $179 +17% |
| Deutsche Bank | 69 % | +6.2 % | 26 | $162 +6% |
| Barclays | 72 % | +5.0 % | 18 | $152 -1% |
| Wells Fargo | 59 % | +2.3 % | 17 | $164 +7% |
| Raymond James | 56 % | +2.1 % | 9 | $175 +14% |
| JP Morgan | 50 % | +2.0 % | 12 | $162 +6% |
✅ Reasons to believe
- The most reliable firm on PG, Jefferies (86% hit rate, 7 scored calls), targets $179 (call made on December 17, 2025, maturing on December 17, 2026) (+17%) in its most recent call.
- Pays a dividend (2.9% yield) — regular income on top of potential upside.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 12 ratings, 5 are neutral.
- Limited upside: the median target is only +7% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on PG
Median target $164 (+7%) · 12 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Procter & Gamble now?
We won't decide for you. The facts: 58% of analysts rate it a buy, median target $164 (+7%), and Jefferies (most reliable on PG, 86%) targets $179. Weigh that against valuation (P/E ~23). This is not personalized advice.
Is it too late to invest in Procter & Gamble?
Not according to analysts: the median target ($164) is still +7% above the current price ($153) (most reliable on PG: Jefferies, 86%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Procter & Gamble still worth investing in?
It depends on the gap between the price ($153) and its estimated value: analysts target $164 on median (+7%), with 58% buys (most reliable on PG: Jefferies, 86%). Cross-check with their real reliability on PG and the cautions above. Information, not advice.
What's the main risk in buying PG?
The consensus is not unanimous: of 12 ratings, 5 are neutral.
→ Go deeper: the full Procter & Gamble profile (consensus, analyst reliability, price target, performance).